The hows and whys
The neural network field for biomedicine is robust, says Harry Burke, a physician and neural network researcher at New York Medical College in Valhalla. "I run the biomedical applications section of the International Joint Conference on Neural Networks, and we always have 40 or 50 papers at least-perhaps as many as 100-submitted each year."
In the US, the emphasis has been on the use of neural networks to diagnose prostate, cervical, and breast cancer, and several such systems are already in clinical use. In Europe, medical commercial systems use neural networks for sleep analysis and for monitoring patients in intensive care.
"In addition," says Paulo Lisboa of Liverpool John Moores University, UK, "there is a visualization system for gait analysis and an advisory system for the detection and "Neural networks are very much oriented to data-driven computing," says Paul Keller of the Pacific Northwest National Laboratory in Richland, Washington, a Department of Energy National Laboratory operated by the Ohio-based Battelle Institute. In situations where the relationship between the measured parameters and the outcomes is not clear, he says, neural networks can help.
Although there were early attempts to simulate biological neural networkssuch as the Perceptron project at the Massachusetts Institute of Technology that involved the construction of specialized hardware-neural networks today are mostly implemented in software, says
Keller. Some developers, however, are using digital signal processing hardware as a first step up from standard microprocessor chips. Processing speed is not important in most applications, because the bulk of the time needed is for training the network, not for processing working data.
Requirements and regulations
Many of the neural network products under development or approved for clinical use assist in image interpretation, highlighting likely regions of a diagnostic image on which the radiologist or pathologist can focus. The systems are not designed to give a formal diagnosis.
Because these neural-networks are being applied to the field of medicine and can influence the treatment of patients, they face stricter regulations than other applications. "As you know, the [US] Food and Drug Administration has an approval process for medical devices," says David Brown of the FDA's Center for Devices and Radiological Health. The approval process requires the company developing a product to conduct clinical trials and to present the data on safety and reliability to FDA scientists and clinicians. After review by agency staff, the recommendation goes to a panel of outside experts.
"Everything we do is risk driven," Brown says. If there is no risk to the patients, the agency gives the device less scrutiny. That is one reason that companies first submitted diagnosis and prognosis applications for consideration. As neural networks and fuzzy logic become standard engineering tools in controllers for therapeutic devices, such systems will get less scrutiny, he says. However, the explosion of data derived from advanced diagnostic imaging, Brown notes, are driving the development of current neural network applications for assisting diagnosis. The development of 3D imaging (computerized tomography and nuclear magnetic resonance) and of multimodal imaging and the need for correlation between imaging modalities are leading to the application of new data-analysis techniques, such as neural networks.
Developing commercial products
Three diagnostic projects have passed premarket approval by the FDA: two for Pap smear analysis (for detection of cervical cancer) and another for breast cancer detection. In May 1998, NeoPath of Redmond, Washington, which developed an automated Pap smear reader, received approval from the FDA to market its AutoPap system. Additionally, at least two companies are involved in applying neural networks to mammogram image processing: Qualia Computing of Beavercreek, Ohio, which is developing a computeraided detection workstation for mammographic abnormalities, and R2 Technology of Los Altos, California, which received FDA approval in June 1998 to commercially distribute its Image Checker Computer-Aided Detection system. Horus Therapeutics's Zhang notes that the atmosphere regarding neural network medical applications has changed over the past few years. Previously, researchers such as Zhang had to explain neural networks to potential users and to their clinical collaborators. Now, physicians accept neural networks-at least in a number of clinical fields such as urology-as a viable tool for combining multiple clinical inputs for disease detection, staging and prognostication, and monitoring. The company has developed a prostate cancer application that combines data from three serum biomarkers and the patient's age to produce a single-valued diagnostic index, helping physicians to identify patients with a high risk of prostate cancer. Unlike some previous efforts to apply neural networks to medicine, this approach incorporates existing medical knowledge into a complete diagnostic model in which a neural network serves as one component.
Although Horus has completed several retrospective studies involving 2,500 patients whose outcomes are known, the ultimate test for its prostate cancer product is the study of patients whose diagnostic status is unknown at the time of testing-a prospective study. Preliminary data from a pilot prospective study involving 150 patients have been very promising, and plans for a larger, multicenter prospective study are in the works, Zhang says. "We will be seeing more applications in the area of therapy," Brown predicts. Already there are proposals for neural networks to control devices implanted in patients to treat cardiovascular problems (through small shocks for defibrillation) or neurological conditions such as epilepsy (through electrodes implanted in the brain). It is still early, he says, "and we still have a number of tough regulatory calls coming up."
Lisboa agrees that certification, a legal requirement in the European Union as well as in the US, is a key issue for those hoping to apply neural networks to medicine. "There is no accepted methodology to evaluate systems [containing] artificial neural networks," he notes.
Obstacles to commercial development
Three technical issues must be addressed to develop clinically successful applications, according to Lisboa.
First, a system must incorporate means to prevent catastrophic failure of the neural network when it encounters test data that fall outside its training data, by assigning apparently reasonable inferences to those data. This problem is reduced by the self-consistent error measures of some statistical frameworks for neural network design, but it remains an issue for new conditions when values previously considered nuisance variables become important. Existing models will suppress those variables, essentially ignoring them, with the effect that the condition can masquerade as an existing one, he says.
Second, researchers need to determine how many instances the neural network must be exposed to in the training set to accurately detect a condition with a given error rate.
"This is the bread and butter of medical statisticians, but the calculations do not extend trivially to artificial neural networks," Lisboa says. This can substantially impact the cost of clinical trials. Some researchers are now parameterizing generalization neural network performance explicitly as a function of the number of training and validation samples used, but this is still in its infancy, he notes. "The problem is that, unlike linear statistics, the number of samples required to assure a given performance depends on the complexity of the data."
Finally, few reliable methods exist that can deal with missing data. "This is endemic in [neural network] medical applications, but self-consistent nonlinear inference of missing values is a very hard problem," Lisboa says. "It may be possible to use other methods to fill in or ignore these data, but their impact on a subsequent nonlinear model must then be estimated." Nor is missing data the only problem. Lisboa says mislabeled data is also frequent in clinical studies.
Apart from these issues, there are the difficulties-ubiquitous in medical practice-of standardizing data acquisition and of obtaining meaningful-sized samples. Furthermore, there are the difficulties of financing start-up companies.
For example, Neuromedical Systems brought Papnet, its cervical cancer screening tool, through the FDA approval process, only to fall into bankruptcy and then sell its intellectual property to its rivals. "These factors may end up having a greater impact on the use of artificial neural networks in biomedicine than the technology," Lisboa says.
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Constraints
Technology transfer at knife's edge
Dale Strok, dstrok@computer.org
What makes one instance of a search problem harder than another? Both underconstrained and overconstrained problems tend to be relatively easy to solve; in the first case, you easily stumble across a solution, and in the second the bottlenecks are typically fairly obvious. The hardest problems tend to be in between, when problems are on the "knife edge." With the benefit of funds from the United Kingdom's Engineering and Physical Sciences Research Council, computer scientists from the APES (Algorithms, Problems, and Empirical Studies) research group at the University of Strathclyde spent the last three years trying to answer this question. With the project's close at the end of 1999, they have some answers (for more information, see apes.cs. strath.ac.uk/kappa.html).
The key to their success was formalizing the notion of the constrainedness of a search problem. If you measure the constrainedness of problems as you move deeper in a search tree, you tend to observe a "constrainedness knife edge" in which critically constrained problems tend to remain critically constrained, but under-and overconstrained problems become more under-and overconstrained. This helps to explain why problems from the phase transition are difficult to solve.
APES chose kappa, the 10th letter of the Greek alphabet, as the symbol for its definition of the constrainedness of a group of search problems. Such constrainedness depends on both the problem size and the expected number of solutions. APES therefore defines constrainedness as kappa = 1 -log(<Sol>)/N, where <Sol> is the expected number of search states that are solutions and N is the problem size (log 2 of the number of search states). This definition ignores other factors that could contribute to a constrainedness measure, such as structure and symmetry, but it is a good first approximation.
Once they had this general definition, the researchers were able to see such knife-edge behavior in a wide range of computational problems. APES has used kappa to locate phase transitions and to model behavior at finite sizes. It has proved useful in a variety of domains: in polynomial problems such as achieving arc consistency, in NP-complete problems as diverse as number partitioning and the Hamiltonian circuit problem, and in PSPACE-complete problems such as quantified satisfiability.
They have also used the insights gained to design and analyze better algorithms. They looked at the impact of binary versus nonbinary representation on algorithm performance, at preprocessing operations, at branching within search, and at dealing with branching mistakes. Their results included new and promising search algorithms such as depthbounded discrepancy search (DDS) as well as useful insights into algorithm behavior. One of the most practical benefits of this project was showing that their definition of constrainedness can be used to design such heuristics.
On the way to commercial application
Researcher Toby Walsh is pleased with the project's results. "Although this was basic research, industry has already picked up some of the ideas." One member of the research group, Paul Shaw, left APES and took a job with ILOG spa (www.ilog.fr and www.ilog.com), a constraint toolkit provider, and is now applying APES' results. Shaw is using DDS, which is designed to take advantage of large but underconstrained problems away from the phase transition. In particular, DDS can undo heuristic mistakes high in the search tree at little cost.
Walsh says the Theory Group at Microsoft Research is also interested in APES' results. Here, mathematicians, physicists, and theoretical computer scientists work on problems at the interface of their fields. And constrainedness fits right in.
Merging disciplines
Although most of the people developing neural network clinical applications are mathematicians or computer scientists who team up with physicians, New York Medical College's Burke earned a doctorate in cognitive science and worked on modeling memory processes before becoming a physician. "I've been at this in medicine for almost nine years" and have had much to learn about both neural networks and medical prediction, he says. Burke considers neural networks to be an empirical statistical method that has faced some resistance from the traditional statistics community.
"But neural networks are really just a very powerful method for statistical regression that can effectively capture interactions and nonlinearities," Burke says. Statisticians use regression techniques to find relationships between input variable, such as blood pressure, and output variables or observations, such as the risk of stroke. In a system where there are no interactions among the input variables and nonlinearities, the neural network approach collapses to logistic regression. Neural networks are transparent if the phenomena being modeled are simple, but no statistical method is transparent if the phenomena are complex, he says. However, if neural networks have a weakness, it is that "they are pretty complicated and easy to get wrong."
The drive for better diagnostic techniques is bringing together the domains of computer science, statistics, and medicine through the use of neural networks. "The traditional diagnostic information only gets you so far," Burke says. But the lookup tables used in the past aren't very accurate. "To gain accuracy, you have to move into more powerful predictive factors"-often identified by the use, for example, of molecular genetics-"and more powerful models." 
Constraints.
Friar Tuck-A Constraint-Based TournamentScheduling Tool Martin Henz, henz@comp.nus.
edu.sg
In round-robin sports competitions, each team plays each other once (single roundrobin) or twice (double round-robin). Tournament planners can easily schedule standard round-robin tournaments because there are known algorithms, published tournament schedules, and readily available software. However, with additional constraints, round-robin planning quickly degenerates into a combinatorial search problem-and additional constraints abound in professional sports: team commitments, fan preferences, TV station requirements, and so forth.
Friar Tuck, a constraint-based roundrobin scheduling tool, lets tournament coordinators enter a variety of constraints to compute optimal solutions to complex tournament-planning problems.
A constraint-based approach
George Nemhauser and Michael Trick studied an extreme case involving constraints-the 1997/98 Atlantic Coast Conference in basketball. 1 The ACC includes nine universities, and its basketball program runs an annual double-round-robin tournament. Various constraints limit the possible sequences of home and away matches, assign matches between given teams to particular dates, force teams to play at home (or away) on particular dates, restrict teams from playing against strong teams twice in a row, and so on. Nemhauser and Trick used integer programming and exhaustive enumeration to create schedules that fulfill all constraints. I have found that constraint programming offers significant advantages for modeling and solving round-robin tournament problems 2 and outperforms these operations research techniques on the ACC problem. 3 Usually, round-robin tournament plan-
The Friar Tuck tournament-scheduling tool.
ning is decomposed into three successive phases: finding patterns, generating pattern sets, and developing schedules. Constraint programming can employ symbolic constraints such as all different and element for all three phases. The constraints propagate information in the nodes of the search tree, guide the search, and prune the tree. A constraint-based tree search often finds solutions to tournament-scheduling problems quickly. For example, a state-of-the-art constraint programming system can find all 179 solutions to the ACC problem in one minute on a PC, as opposed to the 24-hour computing time reported by Nemhauser and Trick.
Friar Tuck
Friar Tuck provides users with a variety of constraint editors for round-robin tournaments (www.comp.nus.edu.sg/~henz/projects/ FriarTuck). These editors are expressive enough to formulate the full ACC problem and various other constraints. Users can choose to automatically sequence the solution phases or manually explore the possibilities in each phase. Friar Tuck generates and displays schedules and saves them in HTML format. The figure shows the constraint editor for fixing patterns and opponents, the interface to the solver phases, and the display of a generated schedule. I implemented Friar Tuck in the concurrent constraint language Oz, 4 which combines finite-domain constraint program-
Smart systems
Making ships smarter
Congress has recently approved research funding for the Energy Systems Analysis Consortium (www.ecn.purdue. edu/ESAC) to develop critical technologies for automated warships. Led by engineers at Purdue University (www.purdue. edu) and the University of Missouri-Rolla (www.umr.edu), the ESAC principally deals with the analysis, simulation, control, and design of electrical-energy conversion and distribution with an emphasis on systems and components found on marine, ground, and aerospace vehicles.
"One goal is to build a ship that does not need any maintenance while at sea," says Scott Sudhoff, an associate professor at Purdue University's School of Electrical and Computer Engineering. "It's supposed to be highly robust so that, even if you take a missile hit, that ship can continue to fight its way into battle and continue with its mission without needing any maintenance until returning to port."
The future warships will differ fundamentally from conventional vessels in that they will run on electric motors, and their power sources will not be connected directly to the propellers. Instead, the power source, such as a diesel or gas turbine engine, will drive a large electrical generator. The generator will, in turn, provide electricity for the motors that turn the propellers. According to ESAC, this arrangement will offer more flexibility for naval architects because they can place the power source anywhere on the ship, instead of directly in line with the propellers.
Normally, ship engines are continuously being throttled up and down to propel the vessel at different speeds. However, turbines connected to electrical generators can run at a constant speed, saving fuel, says Sudhoff, who, along with James Drewniak, an associate professor of electrical engineering at the University of Missouri, heads the ESAC's work on the electricpower and propulsion system. The system will let engineers and architects design modular vessels consisting of several redundant "zones." If one zone gets severely damaged in an attack, automatic controls will instantaneously reroute the power to the rest of the ship.
One major challenge in building the next-generation ships is designing an electric power system that can be "automatically reconfigured" to compensate for damaged zones. Such a system is difficult to manage because of the myriad possible pathways over which electricity might have to be rerouted, the numerous pieces of equipment being switched on and off, and the ultrahigh voltages and currents involved.
The voltage and current will be controlled by a method known as "power electronics," in which semiconductor "converters" process electricity. For example, if there is a drop in voltage leading to a piece of equipment, the voltage converts automatically to its proper value so that the equipment remains unaffected. However, converting the power introduces instabilities-which must be fully anticipated and dealt with-to other parts of the system. Otherwise, the entire electrical system could fail, which would be catastrophic in battle.
Predicting the system's behavior under a multitude of conditions requires developing new mathematical testing techniques.
"One of the big focuses of our research," say Sudhoff, "is finding the analytical tools to facilitate designs that can be proven to be stable over all operating conditions."
Recent trends have made automated technologies especially necessary; the US Navy has seen a 33% decrease in military personnel over the last decade and a significant reduction in experienced seamen.
The Navy hopes to have the first "smart ships" in operation by the end of the decade.
Scott Sudhoff, left, an associate professor in Purdue's School of Electrical and Computer Engineering, and research engineer Brian Kuhn work on a piece of equipment being used to develop the electric-power and propulsion system for the Navy's new fleet of automated warships. (photo by David Umberger) ming with a rich language for symbolic processing. I used the programming system Mozart, 5 Tightly constrained round-robin tournaments are showcase applications of constraint programming. To tackle large irregular tournaments that currently lie beyond the capabilities of Friar Tuck, round-robinspecific constraint-propagation algorithms will become important.
